-
Jefferson Capital adds two directors to board
-
Jefferson Capital (JCAP) PT Lowered to $22 at Raymond James
-
Jefferson Capital (JCAP) Reiterated at Market Outperform by Citizens; Results as Expected
-
Jernigan Capital (JCAP) Tops Q4 EPS by 7c
-
Jefferies Reiterates Buy Rating on Jefferson Capital (JCAP): "We estimate a solid 4Q"
-
Texas Capital Securities Starts Jefferson Capital (JCAP) at Buy
-
Jefferson Capital (JCAP) files for 10M share offering by selling stockholders
-
Jefferson Capital (JCAP) files for proposed IPO
-
KBW: 'Jefferson Capital (JCAP) Remains Well Positioned in a Strong Market For Receivables'
-
Jefferson Capital (JCAP) PT Raised to $25 at Raymond James
-
Jefferson Capital (JCAP) Will Have Bulk of EPS Benefit in 2026 - Citizens
-
Jefferson Capital (JCAP) PT Raised to $28 at Keefe, Bruyette & Woods
-
Jefferson Capital (JCAP) PT Raised to $26 at Truist
-
Jefferson Capital (JCAP) PT Raised to $26 at Citizens After EPS Beat - Citizens
-
Jernigan Capital (JCAP) Reports Q3 EPS of $0.74
-
Citizens Reiterates Jefferson Capital (JCAP) at Market Outperform
-
KBW on Jefferson Capital (JCAP): 'Company Appears Well Positioned to Continue to Outperform'
-
Citizens JMP Reiterates Market Outperform Rating on Jefferson Capital (JCAP)
-
Jefferson Capital (JCAP) PT Raised to $22 at Raymond James
-
Citizens JMP Reiterates Market Outperform Rating on Jefferson Capital (JCAP)
-
Jernigan Capital (JCAP) Reports Q2 EPS of $0.81
-
Raymond James Starts Jefferson Capital (JCAP) at Outperform
-
Keefe, Bruyette & Woods Starts Jefferson Capital (JCAP) at Outperform
-
Jefferies Starts Jefferson Capital (JCAP) at Buy
-
Citizens JMP Starts Jefferson Capital (JCAP) at Market Outperform

